Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVMD, INSM, CYTK, REGN, VERA, and represent 38.94% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: RVMD (+$151M), AZN (+$49M), CYTK (+$46M), INSM (+$41M), ROIV (+$32M), BTSG (+$21M), MRK (+$21M), BBIO (+$20M), BSX (+$20M), VRTX (+$18M).
- Started 28 new stock positions in LIVN, IONS, CAPR, VRTX, TMO, IVA, IMCR, IRON, AZN, RLMD.
- Reduced shares in these 10 stocks: MDT (-$65M), ISRG (-$35M), AstraZeneca (-$32M), TEVA (-$31M), PEN (-$31M), TFX (-$31M), CVS (-$25M), , IRTC (-$23M), DXCM (-$20M).
- Sold out of its positions in ALNY, APLS, ACLX, AstraZeneca, BCRX, BRKR, CRL, DOCS, EHC, EYPT.
- Integral Health Asset Management was a net buyer of stock by $125M.
- Integral Health Asset Management has $2.1B in assets under management (AUM), dropping by 3.82%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 86 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revolution Medicines Put Option (RVMD) | 12.8 | $267M | +129% | 2.8M | 97.25 |
|
| Insmed Com Par $.01 (INSM) | 11.7 | $245M | +20% | 1.5M | 163.52 |
|
| Cytokinetics Com New Call Option (CYTK) | 8.2 | $171M | +36% | 2.6M | 65.91 |
|
| Regeneron Pharmaceuticals (REGN) | 3.1 | $66M | -19% | 85k | 772.64 |
|
| Vera Therapeutics Cl A (VERA) | 3.1 | $64M | -11% | 1.6M | 40.23 |
|
| Cardinal Health (CAH) | 2.7 | $57M | +35% | 270k | 211.31 |
|
| Roivant Sciences SHS (ROIV) | 2.6 | $55M | +135% | 2.0M | 27.70 |
|
| Brightspring Health Svcs (BTSG) | 2.5 | $53M | +66% | 1.3M | 42.61 |
|
| Rhythm Pharmaceuticals (RYTM) | 2.5 | $52M | +26% | 600k | 86.97 |
|
| Merck & Co (MRK) | 2.4 | $51M | +70% | 425k | 120.29 |
|
| Edgewise Therapeutics (EWTX) | 2.4 | $50M | +6% | 1.6M | 31.50 |
|
| Astrazeneca Ord (AZN) | 2.4 | $49M | NEW | 250k | 197.22 |
|
| Alignment Healthcare (ALHC) | 2.2 | $45M | +17% | 2.6M | 17.62 |
|
| Novartis Sponsored Adr (NVS) | 1.8 | $38M | 250k | 152.75 |
|
|
| Boston Scientific Corporation (BSX) | 1.7 | $35M | +144% | 550k | 62.75 |
|
| Mineralys Therapeutics Call Option (MLYS) | 1.6 | $34M | +25% | 1.3M | 27.09 |
|
| Lifestance Health Group (LFST) | 1.3 | $27M | +43% | 4.3M | 6.37 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.3 | $26M | +27% | 115k | 228.73 |
|
| Scholar Rock Hldg Corp (SRRK) | 1.2 | $25M | +66% | 500k | 49.16 |
|
| Anthem (ELV) | 1.1 | $22M | +25% | 75k | 292.75 |
|
| Centene Corporation (CNC) | 1.0 | $21M | 650k | 32.74 |
|
|
| Bridgebio Pharma (BBIO) | 1.0 | $20M | NEW | 275k | 74.26 |
|
| Neurocrine Biosciences (NBIX) | 0.9 | $20M | 150k | 131.74 |
|
|
| Glaukos (GKOS) | 0.9 | $19M | -46% | 175k | 107.66 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.9 | $19M | +200% | 300k | 62.70 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $18M | NEW | 40k | 446.54 |
|
| Oric Pharmaceuticals (ORIC) | 0.8 | $18M | +16% | 1.4M | 12.67 |
|
| Alumis (ALMS) | 0.8 | $18M | NEW | 800k | 22.03 |
|
| Fresenius Medical Care Sponsored Adr (FMS) | 0.8 | $18M | +19% | 775k | 22.56 |
|
| Intuitive Surgical Com New (ISRG) | 0.8 | $16M | -68% | 35k | 460.99 |
|
| Uniqure Nv SHS (QURE) | 0.7 | $15M | 900k | 16.35 |
|
|
| Tarsus Pharmaceuticals (TARS) | 0.7 | $14M | 200k | 70.15 |
|
|
| Gilead Sciences (GILD) | 0.7 | $14M | NEW | 100k | 139.37 |
|
| Eli Lilly & Co. (LLY) | 0.7 | $14M | -25% | 15k | 919.77 |
|
| Edwards Lifesciences (EW) | 0.7 | $14M | -47% | 170k | 80.08 |
|
| Cogent Biosciences (COGT) | 0.6 | $14M | NEW | 350k | 38.49 |
|
| Elanco Animal Health (ELAN) | 0.6 | $13M | +120% | 550k | 23.93 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $13M | NEW | 25k | 523.47 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.6 | $13M | 40k | 322.19 |
|
|
| Dianthus Therapeutics (DNTH) | 0.6 | $13M | -45% | 150k | 83.92 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $13M | +25% | 1.5M | 8.38 |
|
| Quest Diagnostics Incorporated (DGX) | 0.6 | $12M | -20% | 60k | 195.98 |
|
| Xenon Pharmaceuticals (XENE) | 0.6 | $12M | NEW | 200k | 58.15 |
|
| Erasca (ERAS) | 0.5 | $11M | NEW | 700k | 16.18 |
|
| Alto Neuroscience Com Shs (ANRO) | 0.5 | $11M | +33% | 500k | 22.48 |
|
| Biogen Idec (BIIB) | 0.5 | $11M | -40% | 60k | 183.33 |
|
| Dex (DXCM) | 0.5 | $11M | -65% | 175k | 62.80 |
|
| Soleno Therapeutics (SLNO) | 0.5 | $11M | 325k | 33.48 |
|
|
| Disc Medicine (IRON) | 0.5 | $11M | NEW | 170k | 63.94 |
|
| Nurix Therapeutics (NRIX) | 0.5 | $11M | +133% | 700k | 15.50 |
|
| CVS Caremark Corporation (CVS) | 0.5 | $11M | -70% | 150k | 71.82 |
|
| Cooper Cos (COO) | 0.5 | $11M | -53% | 150k | 71.50 |
|
| Thermo Fisher Scientific (TMO) | 0.5 | $9.8M | NEW | 20k | 491.53 |
|
| Livanova SHS (LIVN) | 0.5 | $9.5M | NEW | 150k | 63.56 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.5 | $9.5M | +25% | 125k | 75.85 |
|
| Tango Therapeutics (TNGX) | 0.5 | $9.4M | +125% | 450k | 20.92 |
|
| Ionis Pharmaceuticals (IONS) | 0.4 | $9.4M | NEW | 125k | 75.09 |
|
| Sana Biotechnology (SANA) | 0.4 | $9.2M | +6% | 3.2M | 2.88 |
|
| Celcuity (CELC) | 0.4 | $9.1M | 80k | 114.14 |
|
|
| Protara Therapeutics Com Stk (TARA) | 0.4 | $9.1M | -22% | 1.8M | 5.21 |
|
| Envista Hldgs Corp (NVST) | 0.4 | $8.9M | -30% | 350k | 25.37 |
|
| Biohaven (BHVN) | 0.4 | $8.5M | -33% | 1.0M | 8.46 |
|
| Syndax Pharmaceuticals (SNDX) | 0.4 | $8.2M | +75% | 350k | 23.36 |
|
| Viking Therapeutics (VKTX) | 0.4 | $8.1M | +150% | 250k | 32.54 |
|
| Definium Therapeutics Com Shs (DFTX) | 0.4 | $7.6M | NEW | 400k | 18.90 |
|
| Beam Therapeutics (BEAM) | 0.3 | $7.1M | -45% | 300k | 23.83 |
|
| Rezolute Com New (RZLT) | 0.3 | $6.1M | 2.0M | 3.05 |
|
|
| Capricor Therapeutics Com New (CAPR) | 0.3 | $6.1M | NEW | 200k | 30.40 |
|
| Iqvia Holdings (IQV) | 0.3 | $6.0M | NEW | 35k | 170.54 |
|
| Axsome Therapeutics (AXSM) | 0.3 | $5.9M | NEW | 35k | 169.02 |
|
| Protagonist Therapeutics (PTGX) | 0.3 | $5.3M | NEW | 50k | 105.40 |
|
| Evommune Com Shs (EVMN) | 0.2 | $5.2M | +80% | 225k | 22.99 |
|
| Acadia Healthcare (ACHC) | 0.2 | $4.7M | NEW | 200k | 23.39 |
|
| Zimmer Holdings (ZBH) | 0.2 | $4.5M | NEW | 50k | 90.42 |
|
| Forte Biosciences Com New (FBRX) | 0.2 | $3.9M | NEW | 150k | 25.90 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 0.2 | $3.7M | +50% | 150k | 24.66 |
|
| Savara (SVRA) | 0.2 | $3.3M | NEW | 600k | 5.46 |
|
| Relmada Therapeutics (RLMD) | 0.1 | $3.1M | NEW | 450k | 6.96 |
|
| Immunocore Hldgs Ads (IMCR) | 0.1 | $3.0M | NEW | 100k | 30.15 |
|
| Maze Therapeatics (MAZE) | 0.1 | $3.0M | 100k | 29.85 |
|
|
| Tenax Therapeutics Com New (TENX) | 0.1 | $2.7M | 167k | 15.99 |
|
|
| Inhibikase Therapeutics Com New (IKT) | 0.1 | $2.3M | -22% | 1.4M | 1.68 |
|
| Olema Pharmaceuticals (OLMA) | 0.1 | $2.2M | NEW | 150k | 14.91 |
|
| Inventiva Sa Ads (IVA) | 0.1 | $2.2M | NEW | 400k | 5.55 |
|
| Sionna Therapeutics (SION) | 0.1 | $2.0M | NEW | 50k | 40.09 |
|
| Unicycive Therapeutics Com New (UNCY) | 0.1 | $1.5M | NEW | 225k | 6.58 |
|
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2026 Q1 filed May 15, 2026
- Integral Health Asset Management 2025 Q4 filed Feb. 17, 2026
- Integral Health Asset Management 2025 Q3 filed Nov. 14, 2025
- Integral Health Asset Management 2025 Q2 filed Aug. 14, 2025
- Integral Health Asset Management 2025 Q1 filed May 15, 2025
- Integral Health Asset Management 2024 Q4 filed Feb. 14, 2025
- Integral Health Asset Management 2024 Q3 filed Nov. 14, 2024
- Integral Health Asset Management 2024 Q2 filed Aug. 14, 2024
- Integral Health Asset Management 2024 Q1 filed May 15, 2024
- Integral Health Asset Management 2023 Q3 filed Nov. 14, 2023
- Integral Health Asset Management 2023 Q2 filed Aug. 11, 2023
- Integral Health Asset Management 2023 Q1 filed May 9, 2023
- Integral Health Asset Management 2022 Q4 filed Feb. 13, 2023
- Integral Health Asset Management 2022 Q3 filed Nov. 14, 2022
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022
- Integral Health Asset Management 2022 Q1 filed May 12, 2022